STEM CELL - AN OVERVIEW

In 2015, the NRI staff, led by Isacson and Penny Hallett, PhD, co-director with the NRI at McLean and associate professor of psychiatry at Harvard Clinical Faculty, delivered the main proof of lengthy-time period security and advantages of autologous stem cell therapy in a very very relevant Parkinson's condition non-human primate animal product.La